PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.48

+0.8%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (6323)	12/11/1998 8:58:00 AM
From: Henry Niman	Read Replies (1) of 9523

Today's WSJ has an extensive article on the 55% reduction in breast cancer among patients taking LLY's Evista (Raloxifene). The article also discusses patent expirations. Details linked to the New Therapeutics page of biocognizance.com (SERM Table) PFE has begun a breast cancer prevention trial with their most advanced SERM (Droloxifene) and they have another SERM (CP-366,156) in trials. Details linked to Ligand Clinical Trials page.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next